Trajectories of tuberculosis-specific interferon-gamma release assay responses among medical and nursing students in rural India

Journal of Epidemiology and Global Health

Volumn 3, Issue 2, 2013, Pages 105-117

  Zwerling, Alice ^a,d   Joshi, Rajnish ^b   Kalantri, S P ^c   Dakshinamoorthy, Gajalakshmi ^c   Reddy, Maryada Venkatarama ^c   Benedetti, Andrea ^a,d   Schwartzman, Kevin ^a,d   Menzies, Dick ^a,d   Pai, Madhukar ^a,d  

^a MCGILL UNIVERSITY   (Canada)

^b SIKKIM MANIPAL INSTITUTE OF MEDICAL SCIENCES   (India)

^c MAHATMA GANDHI INSTITUTE OF MEDICAL SCIENCES   (India)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

Health care workers; LTBI; Serial testing; TB screening

Indexed keywords

BCG VACCINE;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HUMAN; ILLNESS TRAJECTORY; INCIDENCE; INDIA; INFECTION CONTROL; INTERFERON GAMMA RELEASE ASSAY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL STUDENT; NURSING STUDENT; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; RURAL AREA; TUBERCULOSIS; VACCINATION;

EID: 84877108159     PISSN: 22106006     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jegh.2013.03.003     Document Type: Article

References (35)

1. World Health Organization. Global Tuberculosis Control 2011. Global Tuberculosis Control 2011 2011;1-258.
2. Chadha V.K. Tuberculosis epidemiology in India: a review. Int J Tuberc Lung Dis 2005, 9(10):1072-1082.
3. Chadha V.K., Kumar P., Jagannatha P.S., Vaidyanathan P.S., Unnikrishnan K.P. Average annual risk of tuberculous infection in India. Int J Tuberc Lung Dis 2005, 9(1):116-118.
4. Joshi R., Reingold A.L., Menzies D., Pai M. Tuberculosis among health-care workers in low- and middle-income countries: a systematic review. PLoS Med 2006, 3(12):e494.
5. Menzies D., Joshi R., Pai M. Risk of tuberculosis infection and disease associated with work in health care settings. Int J Tuberc Lung Dis 2007, 11(6):593-605.
6. Christopher D.J., James P., Daley P., et al. High annual risk of tuberculosis infection among nursing students in South India: a cohort study. PLoS One 2011, 6(10):e26199.
7. Joshi R., Narang U., Zwerling A., et al. Predictive value of latent tuberculosis tests in Indian healthcare workers: a cohort study. Eur Respir J 2011, 38(6):1475-1477.
8. WHO. WHO policy on TB infection control in health-care facilities, congregate settings and households WHO policy on TB infection control in health-care facilities, congregate settings and households, 2009.
9. Chan E.D., Iseman M.D. Multidrug-resistant and extensively drug-resistant tuberculosis: a review. Curr Opin Infect Dis 2008, 21(6):587-595.
10. Chan E.D., Strand M.J., Iseman M.D. Treatment outcomes in extensively resistant tuberculosis. N Engl J Med 2008, 359(6):657-659.
11. Raj R., Prasad H., Arya B.K., Bhattacharya S.D. Isoniazid preventive therapy programmes for healthcare workers in India: translating evidence into policy. Natl Med J India 2011, 24(4):201-207.
12. Menzies D., Pai M., Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007, 146(5):340-354.
13. Diel R., Loddenkemper R., Nienhaus A. Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a metaanalysis. Chest 2010, 137(4):952-968.
14. Zwerling A., Van Den Hof S., Scholten J., Cobelens F., Menzies D., Pai M. Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic review. Thorax 2012, 67(1):62-70.
15. Pai M., Joshi R., Dogra S., et al. Serial testing of health care workers for tuberculosis using interferon-gamma assay. Am J Respir Crit Care Med 2006, 174(3):349-355.
16. Fong K.S., Tomford J.W., Teixeira L., et al. Challenges of interferon-gamma release assay conversions in serial testing of health care workers in a tuberculosis control program. Chest 2012, 142(1):55-62.
17. Joshi M., Monson T.P., Woods G.L. Use of interferon-gamma release assays in a health care worker screening program: experience from a tertiary care centre in the United States. Can Respir J 2012, 19(2):84-88.
18. Pai M., Gokhale K., Joshi R., et al. Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon gamma assay with tuberculin skin testing. JAMA 2005, 293(22):2746-2755.
19. Van Zyl-Smit R.N., Zwerling A., Dheda K., Pai M. Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review. PLoS One 2009, 4(12):e8517.
20. Mazurek G.H., Jereb J., Vernon A., Lobue P., Goldberg S., Castro K. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection-United States. MMWR Recomm Rep 2010, 59(RR-5):1-25.
21. Zwerling A., Cojocariu M., Mcintosh F., et al. TB screening in Canadian health care workers using interferon-gamma release assays. PLoS One 2012, 7(8):e43014.
22. Pai M. Spectrum of latent tuberculosis-existing tests cannot resolve the underlying phenotypes. Nat Rev Microbiol 2010, 8(3):242. [author reply 242].
23. Biesheuvel C.J., Vergouwe Y., Steyerberg E.W., Grobbee D.E., Moons K.G. Polytomous logistic regression analysis could be applied more often in diagnostic research. J Clin Epidemiol 2008, 61(2):125-134.
24. Zeger S.L., Liang K.Y. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986, 42(1):121-130.
25. Neuhaus J.M., Kalbfleisch J.D. Between- and within-cluster covariate effects in the analysis of clustered data. Biometrics 1998, 54(2):638-645.
26. Twisk J., Rijmen F. Longitudinal to bit regression: a new approach to analyze outcome variables with floor or ceiling effects. J Clin Epidemiol 2009, 62(9):953-958.
27. Zwerling A., Benedetti A., Cojocariu M., et al. Repeat IGRA testing in Canadian health workers: conversions or unexplained variability?. PLoS One 2013, 8(1):e54748.
28. Adetifa I.M., Ota M.O., Jeffries D.J., et al. Interferon-gamma ELISPOT as a biomarker of treatment efficacy in latent tuberculosis infection: a clinical trial. Am J Respir Crit Care Med 2013, 187(4):439-445.
29. Denkinger C.M., Pai M., Patel M., Menzies D. Gamma interferon release assay for monitoring of treatment response for active tuberculosis: an explosion in the spaghetti factory. J Clin Microbiol 2013, 51(2):607-610.
30. Slater M., Parsonnet J., Banaei N. Investigation of false-positive results given by the QuantiFERON-TB Gold In-Tube assay. J Clin Microbiol 2012, 50(9):3105-3107.
31. Doberne D., Gaur R.L., Banaei N. Preanalytical delay reduces sensitivity of QuantiFERON-TB gold in-tube assay for detection of latent tuberculosis infection. J Clin Microbiol 2011, 49(8):3061-3064.
32. Herrera V., Yeh E., Murphy K., Parsonnet J., Banaei N. Immediate incubation reduces indeterminate results for QuantiFERON-TB Gold in-tube assay. J Clin Microbiol 2010, 48(8):2672-2676.
33. Shanaube K., De Haas P., Schaap A., et al. Intra-assay reliability and robustness of QuantiFERON(R)-TB Gold In-Tube test in Zambia. Int J Tuberc Lung Dis 2010, 14(7):828-833.
34. Whitworth W.C., Hamilton L.R., Goodwin D.J., et al. Within-subject interlaboratory variability of QuantiFERON-TB gold in-tube tests. PLoS One 2012, 7(9):e43790.
35. Pai M. Serial testing with TB interferon-g release assays: toward a nuanced understanding. Chest 2012, 142:1366-1368.